Your browser doesn't support javascript.
loading
Mechanism of Action and Efficacy of Immunosupressors in Lupus Nephritis.
Alamilla-Sanchez, Mario E; Alcala-Salgado, Miguel A; Alonso-Bello, Cesar D; Fonseca-Gonzalez, Gandhy T.
Afiliação
  • Alamilla-Sanchez ME; Department of Nephrology, Centro Medico Nacional "20 de Noviembre", Mexico City, Mexico.
  • Alcala-Salgado MA; Department of Nephrology, Centro Medico Nacional "20 de Noviembre", Mexico City, Mexico.
  • Alonso-Bello CD; Department of Immunology, Centro Medico Nacional "20 de Noviembre", Mexico City, Mexico.
  • Fonseca-Gonzalez GT; Department of Nephrology, Centro Medico Nacional "20 de Noviembre", Mexico City, Mexico.
Int J Nephrol Renovasc Dis ; 14: 441-458, 2021.
Article em En | MEDLINE | ID: mdl-34924767
Approximately 70% of the patients with systemic lupus erythematosus will have clinical evidence of kidney damage during their evolution. Patients with impaired renal function at onset and those with recurrent flares have a poor prognosis. Understanding the mechanism of action of immunosuppressants is essential for proper prescription. Steroids inhibit the DNA sequence that promotes the release of inflammatory cytokines. Phosphoramide mustard, metabolite of cyclophosphamide, cross-link with the DNA, causing the aggregation of an alkyl group, causing cell death. Mycophenolate inhibits inosine monophosphate dehydrogenase, prevents de novo synthesis of guanine, inducing cell arrest in S phase. Azathioprine blocks the synthesis of purines and induces apoptosis. Calcineurin inhibitors prevent the dephosphorylation of NFAT and reduce the production of interleukin 2. Antimalarials alter the enzymatic release of lysosomes by increasing intravesicular pH. The mechanism of action of rituximab is related to complement-dependent cytotoxicity and the elimination of anti-CD20-labeled B cells. Progress in the knowledge and management of low doses of steroids may change the current paradigm and reduce the frequency of related adverse events. Mycophenolate seems to be a better choice than cyclophosphamide for induction, it is also preferred over azathioprine as a maintenance immunosuppressive agent, although azathioprine is preferred in women with a desire for conception, those pregnant, or with low resources. For treatment-resistant cases, tacrolimus, rituximab or belimumab may be effective. Ongoing clinical trials with new drugs offer promising results.
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: Int J Nephrol Renovasc Dis Ano de publicação: 2021 Tipo de documento: Article País de afiliação: México País de publicação: Nova Zelândia

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: Int J Nephrol Renovasc Dis Ano de publicação: 2021 Tipo de documento: Article País de afiliação: México País de publicação: Nova Zelândia